Published in Cell on September 12, 2013
Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron (2014) 2.83
Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med (2014) 1.85
Atomic Resolution Structure of Monomorphic Aβ42 Amyloid Fibrils. J Am Chem Soc (2016) 1.49
Inflammasomes in the CNS. Nat Rev Neurosci (2014) 1.44
Aβ(1-42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease. Nat Struct Mol Biol (2015) 1.42
Serial propagation of distinct strains of Aβ prions from Alzheimer's disease patients. Proc Natl Acad Sci U S A (2014) 1.34
Rapid proton-detected NMR assignment for proteins with fast magic angle spinning. J Am Chem Soc (2014) 1.29
Neurodegenerative diseases: expanding the prion concept. Annu Rev Neurosci (2015) 1.24
Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein. Nat Struct Mol Biol (2016) 1.22
Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target. J Biol Chem (2014) 1.20
Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice. Proc Natl Acad Sci U S A (2014) 1.18
Atomic-resolution three-dimensional structure of amyloid β fibrils bearing the Osaka mutation. Angew Chem Int Ed Engl (2014) 1.14
Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs). Chem Rev (2014) 1.10
The red-hot debate about transmissible Alzheimer's. Nature (2016) 1.02
Transient dynamics of Aβ contribute to toxicity in Alzheimer's disease. Cell Mol Life Sci (2014) 1.01
Somatic mosaicism in the human genome. Genes (Basel) (2014) 0.99
Physical and structural basis for polymorphism in amyloid fibrils. Protein Sci (2014) 0.99
Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes. Nature (2017) 0.99
Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights. Adv Exp Med Biol (2015) 0.98
Yeast prions: structure, biology, and prion-handling systems. Microbiol Mol Biol Rev (2015) 0.98
Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration. Cell Rep (2015) 0.96
X-ray crystallographic structures of trimers and higher-order oligomeric assemblies of a peptide derived from Aβ(17-36). J Am Chem Soc (2014) 0.96
Amyloid polymorphism: structural basis and neurobiological relevance. Neuron (2015) 0.95
Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways. Mol Cell Neurosci (2015) 0.94
High resolution structural characterization of Aβ42 amyloid fibrils by magic angle spinning NMR. J Am Chem Soc (2015) 0.93
Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis. Molecules (2015) 0.92
Locating folds of the in-register parallel β-sheet of the Sup35p prion domain infectious amyloid. Proc Natl Acad Sci U S A (2014) 0.89
Structural and kinetic analysis of protein-aggregate strains in vivo using binary epitope mapping. Proc Natl Acad Sci U S A (2015) 0.89
A template for new drugs against Alzheimer's disease. Cell (2013) 0.88
The OPEP protein model: from single molecules, amyloid formation, crowding and hydrodynamics to DNA/RNA systems. Chem Soc Rev (2014) 0.88
Multimodal fluorescence microscopy of prion strain specific PrP deposits stained by thiophene-based amyloid ligands. Prion (2014) 0.88
Prions and Protein Assemblies that Convey Biological Information in Health and Disease. Neuron (2016) 0.87
Fibril elongation by Aβ(17-42): kinetic network analysis of hybrid-resolution molecular dynamics simulations. J Am Chem Soc (2014) 0.87
Disordered amyloidogenic peptides may insert into the membrane and assemble into common cyclic structural motifs. Chem Soc Rev (2014) 0.86
Site-specific structural variations accompanying tubular assembly of the HIV-1 capsid protein. J Mol Biol (2013) 0.86
There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS. Brain Res (2016) 0.85
Nano-mole scale side-chain signal assignment by 1H-detected protein solid-state NMR by ultra-fast magic-angle spinning and stereo-array isotope labeling. PLoS One (2015) 0.85
Axonal transport and secretion of fibrillar forms of α-synuclein, Aβ42 peptide and HTTExon 1. Acta Neuropathol (2016) 0.84
Crystal structure reveals conservation of amyloid-β conformation recognized by 3D6 following humanization to bapineuzumab. Alzheimers Res Ther (2014) 0.84
The C-terminal threonine of Aβ43 nucleates toxic aggregation via structural and dynamical changes in monomers and protofibrils. Biochemistry (2014) 0.84
Structure and assembly of the mouse ASC inflammasome by combined NMR spectroscopy and cryo-electron microscopy. Proc Natl Acad Sci U S A (2015) 0.84
β-Helical architecture of cytoskeletal bactofilin filaments revealed by solid-state NMR. Proc Natl Acad Sci U S A (2014) 0.84
Solid-State Nuclear Magnetic Resonance on the Static and Dynamic Domains of Huntingtin Exon-1 Fibrils. Biochemistry (2015) 0.83
Mammalian prions and their wider relevance in neurodegenerative diseases. Nature (2016) 0.83
Fiber diffraction of the prion-forming domain HET-s(218-289) shows dehydration-induced deformation of a complex amyloid structure. Biochemistry (2014) 0.83
Phosphorylation modifies the molecular stability of β-amyloid deposits. Nat Commun (2016) 0.83
Aggregation interplay between variants of the RepA-WH1 prionoid in Escherichia coli. J Bacteriol (2014) 0.83
Effect of the English familial disease mutation (H6R) on the monomers and dimers of Aβ40 and Aβ42. ACS Chem Neurosci (2014) 0.83
Polymorphism of Amyloid Fibrils In Vivo. Angew Chem Int Ed Engl (2016) 0.82
Molecular structure of monomorphic peptide fibrils within a kinetically trapped hydrogel network. Proc Natl Acad Sci U S A (2015) 0.82
Atomic-resolution structure of cytoskeletal bactofilin by solid-state NMR. Sci Adv (2015) 0.82
X-ray Crystallographic Structures of a Trimer, Dodecamer, and Annular Pore Formed by an Aβ17-36 β-Hairpin. J Am Chem Soc (2016) 0.82
Different 2-Aminothiazole Therapeutics Produce Distinct Patterns of Scrapie Prion Neuropathology in Mouse Brains. J Pharmacol Exp Ther (2015) 0.82
Single mutations in tau modulate the populations of fibril conformers through seed selection. Angew Chem Int Ed Engl (2014) 0.82
Characterizing methyl-bearing side chain contacts and dynamics mediating amyloid β protofibril interactions using ¹³C(methyl)-DEST and lifetime line broadening. Angew Chem Int Ed Engl (2014) 0.82
Identification and Structural Characterization of the N-terminal Amyloid Core of Orb2 isoform A. Sci Rep (2016) 0.81
Neurodegeneration: Alzheimer's disease under strain. Nature (2014) 0.81
Structural studies of truncated forms of the prion protein PrP. Biophys J (2015) 0.81
Measurement of amyloid formation by turbidity assay-seeing through the cloud. Biophys Rev (2016) 0.81
Structural Polymorphism of Alzheimer's β-Amyloid Fibrils as Controlled by an E22 Switch: A Solid-State NMR Study. J Am Chem Soc (2016) 0.81
Distinct Spacing Between Anionic Groups: An Essential Chemical Determinant for Achieving Thiophene-Based Ligands to Distinguish β-Amyloid or Tau Polymorphic Aggregates. Chemistry (2015) 0.81
Systematic Aβ Analysis in Drosophila Reveals High Toxicity for the 1-42, 3-42 and 11-42 Peptides, and Emphasizes N- and C-Terminal Residues. PLoS One (2015) 0.81
Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology. Acta Neuropathol (2015) 0.81
A novel and rapid method for obtaining high titre intact prion strains from mammalian brain. Sci Rep (2015) 0.81
The hairpin conformation of the amyloid β peptide is an important structural motif along the aggregation pathway. J Biol Inorg Chem (2014) 0.81
X-ray Crystallographic Structures of Oligomers of Peptides Derived from β2-Microglobulin. J Am Chem Soc (2015) 0.81
Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases. J Parkinsons Dis (2015) 0.81
NMR Meets Tau: Insights into Its Function and Pathology. Biomolecules (2016) 0.81
A synchrotron-based hydroxyl radical footprinting analysis of amyloid fibrils and prefibrillar intermediates with residue-specific resolution. Biochemistry (2014) 0.80
β-Amyloid peptides and amyloid plaques in Alzheimer's disease. Neurotherapeutics (2015) 0.80
Structure-Based Peptide Design to Modulate Amyloid Beta Aggregation and Reduce Cytotoxicity. PLoS One (2015) 0.80
Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity. Sci Rep (2015) 0.80
Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease. Prion (2016) 0.80
Characterization of a Novel Mouse Model of Alzheimer's Disease--Amyloid Pathology and Unique β-Amyloid Oligomer Profile. PLoS One (2015) 0.80
Structural Mechanism of the Interaction of Alzheimer Disease Aβ Fibrils with the Non-steroidal Anti-inflammatory Drug (NSAID) Sulindac Sulfide. J Biol Chem (2015) 0.80
Recent advances in solid-state nuclear magnetic resonance techniques to quantify biomolecular dynamics. Anal Chem (2014) 0.80
A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling. J Struct Biol (2016) 0.80
Membrane proteins in their native habitat as seen by solid-state NMR spectroscopy. Protein Sci (2015) 0.80
Potential mechanisms and implications for the formation of tau oligomeric strains. Crit Rev Biochem Mol Biol (2016) 0.79
Structural Conversion of Aβ17-42 Peptides from Disordered Oligomers to U-Shape Protofilaments via Multiple Kinetic Pathways. PLoS Comput Biol (2015) 0.79
Alternative salt bridge formation in Aβ-a hallmark of early-onset Alzheimer's disease? Front Mol Biosci (2015) 0.79
A distinct subfraction of Aβ is responsible for the high-affinity Pittsburgh compound B-binding site in Alzheimer's disease brain. J Neurochem (2014) 0.79
Specific aromatic foldamers potently inhibit spontaneous and seeded Aβ42 and Aβ43 fibril assembly. Biochem J (2014) 0.79
Protective effects of components of the Chinese herb grassleaf sweetflag rhizome on PC12 cells incubated with amyloid-beta42. Neural Regen Res (2015) 0.79
High-resolution NMR characterization of low abundance oligomers of amyloid-β without purification. Sci Rep (2015) 0.79
W8, a new Sup35 prion strain, transmits distinctive information with a conserved assembly scheme. Prion (2015) 0.79
Line-Broadening in Low-Temperature Solid-State NMR Spectra of Fibrils. J Biomol NMR (2017) 0.79
Nucleation of polymorphic amyloid fibrils. Biophys J (2015) 0.78
Tunable assembly of amyloid-forming peptides into nanosheets as a retrovirus carrier. Proc Natl Acad Sci U S A (2015) 0.78
Is membrane homeostasis the missing link between inflammation and neurodegenerative diseases? Cell Mol Life Sci (2015) 0.78
Structure determination of helical filaments by solid-state NMR spectroscopy. Proc Natl Acad Sci U S A (2016) 0.78
Cell Damage in Light Chain Amyloidosis: FIBRIL INTERNALIZATION, TOXICITY AND CELL-MEDIATED SEEDING. J Biol Chem (2016) 0.78
Progress towards structural understanding of infectious sheep PrP-amyloid. Prion (2014) 0.78
A critical role for the self-assembly of Amyloid-β1-42 in neurodegeneration. Sci Rep (2016) 0.78
Experimental Protein Structure Verification by Scoring with a Single, Unassigned NMR Spectrum. Structure (2015) 0.78
Control of the structural landscape and neuronal proteotoxicity of mutant Huntingtin by domains flanking the polyQ tract. Elife (2016) 0.77
Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease. Neurobiol Aging (2016) 0.77
Assembly of Peptides Derived from β-Sheet Regions of β-Amyloid. J Am Chem Soc (2016) 0.77
Suppression of amyloid fibrils using the GroEL apical domain. Sci Rep (2016) 0.77
Molecular basis of substrate recognition and degradation by human presequence protease. Structure (2014) 0.77
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol (2004) 21.56
A specific amyloid-beta protein assembly in the brain impairs memory. Nature (2006) 16.19
TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J Biomol NMR (2009) 16.09
Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med (1998) 9.01
Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science (2005) 8.86
3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc Natl Acad Sci U S A (2005) 8.60
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell (2005) 8.40
Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol (2008) 7.95
Mechanisms underlying inflammation in neurodegeneration. Cell (2010) 7.66
The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry (1993) 7.26
Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA (2011) 6.92
Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci (2001) 6.61
Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry (2006) 6.54
Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science (2006) 6.47
Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron (1994) 6.41
Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol Aging (1997) 5.66
Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci U S A (2002) 5.46
Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem (2003) 5.34
Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res (2008) 5.29
Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem (2004) 5.14
Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol (1994) 5.12
Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils. Proc Natl Acad Sci U S A (2008) 4.84
Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem (1999) 4.64
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. Ann Neurol (2011) 4.38
Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem (1996) 3.84
Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils. Nat Struct Mol Biol (2010) 3.75
Propagating structure of Alzheimer's beta-amyloid(10-35) is parallel beta-sheet with residues in exact register. Proc Natl Acad Sci U S A (1998) 3.74
Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nat Struct Biol (1995) 3.44
Structural and dynamic features of Alzheimer's Abeta peptide in amyloid fibrils studied by site-directed spin labeling. J Biol Chem (2002) 3.37
Frequency selective heteronuclear dipolar recoupling in rotating solids: accurate (13)C-(15)N distance measurements in uniformly (13)C,(15)N-labeled peptides. J Am Chem Soc (2001) 3.26
Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). J Biol Chem (1995) 3.17
Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid. Nat Struct Mol Biol (2007) 3.06
3D TEDOR NMR experiments for the simultaneous measurement of multiple carbon-nitrogen distances in uniformly (13)C,(15)N-labeled solids. J Am Chem Soc (2002) 3.03
Structural features of the Abeta amyloid fibril elucidated by limited proteolysis. Biochemistry (2001) 2.64
Diluting abundant spins by isotope edited radio frequency field assisted diffusion. J Am Chem Soc (2004) 2.50
Inflammation, microglia, and Alzheimer's disease. Neurobiol Dis (2009) 2.44
Purified and synthetic Alzheimer's amyloid beta (Aβ) prions. Proc Natl Acad Sci U S A (2012) 2.36
Seeded growth of beta-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure. Proc Natl Acad Sci U S A (2009) 2.15
Multiple assembly pathways underlie amyloid-beta fibril polymorphisms. J Mol Biol (2005) 2.14
Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction. Neurobiol Dis (2009) 2.12
Symmetry-based constant-time homonuclear dipolar recoupling in solid state NMR. J Chem Phys (2007) 1.94
Abeta(1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. J Mol Biol (2008) 1.86
Proton assisted recoupling and protein structure determination. J Chem Phys (2008) 1.83
A new structural model of Aβ40 fibrils. J Am Chem Soc (2011) 1.78
Molecular basis for amyloid-beta polymorphism. Proc Natl Acad Sci U S A (2011) 1.76
Abeta(1-40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated. J Mol Biol (2010) 1.74
Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition. J Neurosci (2011) 1.66
Antiparallel β-sheet architecture in Iowa-mutant β-amyloid fibrils. Proc Natl Acad Sci U S A (2012) 1.60
Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease. J Biol Chem (2008) 1.57
Amyloid structure: conformational diversity and consequences. Annu Rev Biochem (2011) 1.57
Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues. Biochemistry (2001) 1.54
Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains. J Biol Chem (2009) 1.52
Interprotofilament interactions between Alzheimer's Abeta1-42 peptides in amyloid fibrils revealed by cryoEM. Proc Natl Acad Sci U S A (2009) 1.45
Measurement of amyloid fibril mass-per-length by tilted-beam transmission electron microscopy. Proc Natl Acad Sci U S A (2009) 1.28
Abeta42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta42 species. J Biol Chem (2010) 1.28
Solid-state NMR spectroscopic investigation of Aβ protofibrils: implication of a β-sheet remodeling upon maturation into terminal amyloid fibrils. Angew Chem Int Ed Engl (2011) 1.24
Amide solvent protection analysis demonstrates that amyloid-beta(1-40) and amyloid-beta(1-42) form different fibrillar structures under identical conditions. Biochem J (2007) 1.24
ADDLs and the signaling web that leads to Alzheimer's disease. Neuropharmacology (2010) 1.18
Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages. Neurobiol Aging (2007) 1.17
Structural properties of EGCG-induced, nontoxic Alzheimer's disease Aβ oligomers. J Mol Biol (2012) 1.16
Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts. Brain Res Brain Res Rev (1997) 1.14
Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity. Metallomics (2011) 1.11
Structural evolution of Iowa mutant β-amyloid fibrils from polymorphic to homogeneous states under repeated seeded growth. J Am Chem Soc (2011) 1.10
Polymorph-specific kinetics and thermodynamics of β-amyloid fibril growth. J Am Chem Soc (2013) 1.09
Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis. Acta Neuropathol (2009) 1.09
Long-range correlations between aliphatic 13C nuclei in protein MAS NMR spectroscopy. Angew Chem Int Ed Engl (2009) 1.00
Restraints on backbone conformations in solid state NMR studies of uniformly labeled proteins from quantitative amide 15N-15N and carbonyl 13C-13C dipolar recoupling data. J Magn Reson (2012) 0.96
A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci U S A (2002) 9.55
Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science (2005) 8.86
Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell (2012) 6.83
Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry (2006) 6.54
Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils. Proc Natl Acad Sci U S A (2008) 4.84
Regulation of T cell receptor activation by dynamic membrane binding of the CD3epsilon cytoplasmic tyrosine-based motif. Cell (2008) 4.00
Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. Biochemistry (2007) 3.57
Open-to-closed transition in apo maltose-binding protein observed by paramagnetic NMR. Nature (2007) 3.21
Amyloid of the prion domain of Sup35p has an in-register parallel beta-sheet structure. Proc Natl Acad Sci U S A (2006) 2.88
Supramolecular structure in full-length Alzheimer's beta-amyloid fibrils: evidence for a parallel beta-sheet organization from solid-state nuclear magnetic resonance. Biophys J (2002) 2.78
Ensemble approach for NMR structure refinement against (1)H paramagnetic relaxation enhancement data arising from a flexible paramagnetic group attached to a macromolecule. J Am Chem Soc (2004) 2.58
Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Biochemistry (2002) 2.37
Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells. Immunity (2002) 2.18
Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity. Cancer Cell (2013) 2.18
Seeded growth of beta-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure. Proc Natl Acad Sci U S A (2009) 2.15
The 2.5 Å structure of CD1c in complex with a mycobacterial lipid reveals an open groove ideally suited for diverse antigen presentation. Immunity (2010) 2.02
Molecular dynamics simulations of Alzheimer's beta-amyloid protofilaments. J Mol Biol (2005) 1.99
Polymorphic fibril formation by residues 10-40 of the Alzheimer's beta-amyloid peptide. Biophys J (2006) 1.84
Amyloid of Rnq1p, the basis of the [PIN+] prion, has a parallel in-register beta-sheet structure. Proc Natl Acad Sci U S A (2008) 1.80
Parallel beta-sheets and polar zippers in amyloid fibrils formed by residues 10-39 of the yeast prion protein Ure2p. Biochemistry (2005) 1.79
Abeta40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid. Biochemistry (2005) 1.78
Characterization of beta-sheet structure in Ure2p1-89 yeast prion fibrils by solid-state nuclear magnetic resonance. Biochemistry (2007) 1.73
How much backbone motion in ubiquitin is required to account for dipolar coupling data measured in multiple alignment media as assessed by independent cross-validation? J Am Chem Soc (2004) 1.66
Antiparallel β-sheet architecture in Iowa-mutant β-amyloid fibrils. Proc Natl Acad Sci U S A (2012) 1.60
Biomolecular solid state NMR with magic-angle spinning at 25K. J Magn Reson (2008) 1.60
Flanking polyproline sequences inhibit beta-sheet structure in polyglutamine segments by inducing PPII-like helix structure. J Mol Biol (2007) 1.59
Amplitudes of protein backbone dynamics and correlated motions in a small alpha/beta protein: correspondence of dipolar coupling and heteronuclear relaxation measurements. Biochemistry (2004) 1.59
Probing site-specific conformational distributions in protein folding with solid-state NMR. Proc Natl Acad Sci U S A (2005) 1.57
Recommendations of the wwPDB NMR Validation Task Force. Structure (2013) 1.57
Antibiotic prophylaxis for shock wave lithotripsy in patients with sterile urine before treatment may be unnecessary: a systematic review and meta-analysis. J Urol (2012) 1.53
Low-temperature dynamic nuclear polarization at 9.4 T with a 30 mW microwave source. J Magn Reson (2010) 1.49
Heavy smoking before coronary surgical procedures affects the native matrix metalloproteinase-2 and matrix metalloproteinase-9 gene expression in saphenous vein conduits. Ann Thorac Surg (2012) 1.48
Evidence for novel beta-sheet structures in Iowa mutant beta-amyloid fibrils. Biochemistry (2009) 1.45
Concordance of residual dipolar couplings, backbone order parameters and crystallographic B-factors for a small alpha/beta protein: a unified picture of high probability, fast atomic motions in proteins. J Mol Biol (2006) 1.45
Sensitivity enhancement in structural measurements by solid state NMR through pulsed spin locking. J Magn Reson (2002) 1.45
Peptide-based inhibitors of amyloid assembly. Methods Enzymol (2006) 1.44
Measurement of sample temperatures under magic-angle spinning from the chemical shift and spin-lattice relaxation rate of 79Br in KBr powder. J Magn Reson (2008) 1.44
A mutant chaperone converts a wild-type protein into a tumor-specific antigen. Science (2006) 1.44
Characterization of nonspecific protein-DNA interactions by 1H paramagnetic relaxation enhancement. J Am Chem Soc (2004) 1.43
Increasing the amphiphilicity of an amyloidogenic peptide changes the beta-sheet structure in the fibrils from antiparallel to parallel. Biophys J (2004) 1.41
Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE. J Biol Chem (2007) 1.41
Amyloids of shuffled prion domains that form prions have a parallel in-register beta-sheet structure. Biochemistry (2008) 1.32
Two prion variants of Sup35p have in-register parallel beta-sheet structures, independent of hydration. Biochemistry (2009) 1.30
The functional curli amyloid is not based on in-register parallel beta-sheet structure. J Biol Chem (2009) 1.30
Solid-state NMR yields structural constraints on the V3 loop from HIV-1 Gp120 bound to the 447-52D antibody Fv fragment. J Am Chem Soc (2004) 1.30
Electrostatic contributions to indole-lipid interactions. J Phys Chem B (2005) 1.29
Measurement of amyloid fibril mass-per-length by tilted-beam transmission electron microscopy. Proc Natl Acad Sci U S A (2009) 1.28
An unusual topological structure of the HIV-1 Rev response element. Cell (2013) 1.26
Global molecular structure and interfaces: refining an RNA:RNA complex structure using solution X-ray scattering data. J Am Chem Soc (2008) 1.25
Solution structure of the cap-independent translational enhancer and ribosome-binding element in the 3' UTR of turnip crinkle virus. Proc Natl Acad Sci U S A (2010) 1.23
Solution and membrane-bound conformations of the tandem C2A and C2B domains of synaptotagmin 1: Evidence for bilayer bridging. J Mol Biol (2009) 1.17
Structure and dynamics of full-length HIV-1 capsid protein in solution. J Am Chem Soc (2013) 1.16
A method for helical RNA global structure determination in solution using small-angle x-ray scattering and NMR measurements. J Mol Biol (2009) 1.16
Detection of a transient intermediate in a rapid protein folding process by solid-state nuclear magnetic resonance. J Am Chem Soc (2010) 1.15
Theory for cross effect dynamic nuclear polarization under magic-angle spinning in solid state nuclear magnetic resonance: the importance of level crossings. J Chem Phys (2012) 1.13
Protein fold determined by paramagnetic magic-angle spinning solid-state NMR spectroscopy. Nat Chem (2012) 1.13
Smooth statistical torsion angle potential derived from a large conformational database via adaptive kernel density estimation improves the quality of NMR protein structures. Protein Sci (2012) 1.12
Completely automated, highly error-tolerant macromolecular structure determination from multidimensional nuclear overhauser enhancement spectra and chemical shift assignments. J Am Chem Soc (2004) 1.11
Structural evolution of Iowa mutant β-amyloid fibrils from polymorphic to homogeneous states under repeated seeded growth. J Am Chem Soc (2011) 1.10
Molecular alignment within beta-sheets in Abeta(14-23) fibrils: solid-state NMR experiments and theoretical predictions. Biophys J (2006) 1.09
Frequency-selective homonuclear dipolar recoupling in solid state NMR. J Chem Phys (2006) 1.09
Polymorph-specific kinetics and thermodynamics of β-amyloid fibril growth. J Am Chem Soc (2013) 1.09
pH-triggered, activated-state conformations of the influenza hemagglutinin fusion peptide revealed by NMR. Proc Natl Acad Sci U S A (2012) 1.09
A comparison among four tract dilation methods of percutaneous nephrolithotomy: a systematic review and meta-analysis. Urolithiasis (2013) 1.09
Structure and dynamics of the HIV-1 Vpu transmembrane domain revealed by solid-state NMR with magic-angle spinning. Biochemistry (2006) 1.08
Quantitative determination of site-specific conformational distributions in an unfolded protein by solid-state nuclear magnetic resonance. J Mol Biol (2009) 1.06
Glyoxalase 1 increases anxiety by reducing GABAA receptor agonist methylglyoxal. J Clin Invest (2012) 1.06
The Japanese mutant Aβ (ΔE22-Aβ(1-39)) forms fibrils instantaneously, with low-thioflavin T fluorescence: seeding of wild-type Aβ(1-40) into atypical fibrils by ΔE22-Aβ(1-39). Biochemistry (2011) 1.05
Site-specific identification of non-beta-strand conformations in Alzheimer's beta-amyloid fibrils by solid-state NMR. Biophys J (2003) 1.04
Evidence for a partially structured state of the amylin monomer. Biophys J (2009) 1.04
The core of Ure2p prion fibrils is formed by the N-terminal segment in a parallel cross-β structure: evidence from solid-state NMR. J Mol Biol (2011) 1.03
Combined use of residual dipolar couplings and solution X-ray scattering to rapidly probe rigid-body conformational transitions in a non-phosphorylatable active-site mutant of the 128 kDa enzyme I dimer. J Am Chem Soc (2010) 1.03
Evidence from solid-state NMR for nonhelical conformations in the transmembrane domain of the amyloid precursor protein. Biophys J (2011) 1.02
HIV fusion peptide penetrates, disorders, and softens T-cell membrane mimics. J Mol Biol (2010) 1.02
Segmental polymorphism in a functional amyloid. Biophys J (2011) 1.01
Protein structure refinement using 13C alpha chemical shift tensors. J Am Chem Soc (2009) 1.01
Structural and dynamical characterization of tubular HIV-1 capsid protein assemblies by solid state nuclear magnetic resonance and electron microscopy. Protein Sci (2010) 1.01
Sedimentation studies on human amylin fail to detect low-molecular-weight oligomers. Biophys J (2008) 1.00
Probing the role of backbone hydrogen bonding in beta-amyloid fibrils with inhibitor peptides containing ester bonds at alternate positions. Biochemistry (2003) 1.00
Using the experimentally determined components of the overall rotational diffusion tensor to restrain molecular shape and size in NMR structure determination of globular proteins and protein-protein complexes. J Am Chem Soc (2009) 0.99